These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 29870979)
1. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. Ott C; Gerken M; Hirsch D; Fest P; Fichtner-Feigl S; Munker S; Schnoy E; Stroszczynski C; Vogelhuber M; Herr W; Evert M; Reng M; Schlitt HJ; Klinkhammer-Schalke M; Teufel A Digestion; 2018; 98(3):143-152. PubMed ID: 29870979 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study. Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026 [TBL] [Abstract][Full Text] [Related]
3. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base. Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400 [TBL] [Abstract][Full Text] [Related]
4. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma]. Benedix F; Kuester D; Meyer F; Lippert H Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919 [TBL] [Abstract][Full Text] [Related]
5. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780 [TBL] [Abstract][Full Text] [Related]
6. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor. Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868 [TBL] [Abstract][Full Text] [Related]
7. [Survival rates of patients with mucinous adenocarcinoma of the colorectum]. Maksimović S Med Arh; 2007; 61(1):26-9. PubMed ID: 17582971 [TBL] [Abstract][Full Text] [Related]
8. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Kanemitsu Y; Kato T; Hirai T; Yasui K; Morimoto T; Shimizu Y; Kodera Y; Yamamura Y Dis Colon Rectum; 2003 Feb; 46(2):160-7. PubMed ID: 12576888 [TBL] [Abstract][Full Text] [Related]
9. The association of mucinous histology with clinicopathological characteristics and long-term oncological outcome in patients with colorectal cancer. Tümay V; Guner OS Ann Ital Chir; 2020; 91():639-648. PubMed ID: 32990276 [TBL] [Abstract][Full Text] [Related]
10. The role of adjuvant chemotherapy in stage II and III mucinous colon cancer. Fields AC; Lu P; Goldberg J; Irani J; Bleday R; Melnitchouk N J Surg Oncol; 2019 Dec; 120(7):1190-1200. PubMed ID: 31536150 [TBL] [Abstract][Full Text] [Related]
11. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. Hugen N; Verhoeven RH; Radema SA; de Hingh IH; Pruijt JF; Nagtegaal ID; Lemmens VE; de Wilt JH Ann Oncol; 2013 Nov; 24(11):2819-24. PubMed ID: 24057984 [TBL] [Abstract][Full Text] [Related]
12. Mucinous Histology Signifies Poor Oncologic Outcome in Young Patients With Colorectal Cancer. Soliman BG; Karagkounis G; Church JM; Plesec T; Kalady MF Dis Colon Rectum; 2018 May; 61(5):547-553. PubMed ID: 29578919 [TBL] [Abstract][Full Text] [Related]
13. Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort. Nitsche U; Friess H; Agha A; Angele M; Eckel R; Heitland W; Jauch KW; Krenz D; Nüssler NC; Rau HG; Ruppert R; Schubert-Fritschle G; Wilhelm D; Werner J; Engel J J Cancer Res Clin Oncol; 2016 Nov; 142(11):2357-66. PubMed ID: 27573386 [TBL] [Abstract][Full Text] [Related]
14. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Ayhan M; Turan N; Köstek O; Tufan G; Tataroğlu Özyükseler D; Odabas H; Sakin A; Turan M; Sürmeli H; Yıldırım ME Curr Probl Cancer; 2021 Jun; 45(3):100670. PubMed ID: 33129567 [TBL] [Abstract][Full Text] [Related]
15. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Negri FV; Wotherspoon A; Cunningham D; Norman AR; Chong G; Ross PJ Ann Oncol; 2005 Aug; 16(8):1305-10. PubMed ID: 15857840 [TBL] [Abstract][Full Text] [Related]
16. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study. Wu X; Lin H; Li S BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167 [TBL] [Abstract][Full Text] [Related]
17. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients. Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464 [TBL] [Abstract][Full Text] [Related]
18. Inverse effect of mucinous component on survival in stage III colorectal cancer. Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953 [TBL] [Abstract][Full Text] [Related]
19. Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy. Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY BMC Cancer; 2019 May; 19(1):421. PubMed ID: 31060539 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis. Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]